Europe inset Middle East inset Health-Care Capabilities ... Report_ICA Global Health 2008...
1
Area of Europe inset Area of Middle East inset Area of Caribbean inset Europe inset Middle East inset Caribbean inset Health-Care Capabilities Boundary representation is not necessarily authoritative. Source: National Center for Medical Intelligence. Countries with modern health-care infrastructure, providing high-quality care to most of the population. Pharmaceutical availability and production capability are excellent. These high-income economies have more than sufficient budgetary resources. Health care and public health education are a high national priority. Countries with developed health--care infrastructure, with quality care available to a large percentage of the population. Pharmaceuticals usually are available; production capability is adequate. Upper-middle-income economies, with sufficient budgetary resources to meet the needs of the population. Health care is a high national priority. Countries with developed health-care infrastructure. Medical care generally is available, but relatively large sectors of the population lack adequate care. Tertiary care generally is available, at least in major urban areas; primary health care exists but is underdeveloped. Pharmaceutical availability is good in urban areas; minimally available in rural areas. Production capabilities are generally limited but may be under rapid development. Lower-middle-income economies; budgetary resources generally are available but often are not efficiently used. Health care is of national importance but may be overshadowed by other pressing demands (i.e., political instability, conflict). Countries with less developed health-care infrastructure. Medical care is unavailable to large sectors of the population. Tertiary care is minimally available; primary and secondary health care is rudimentary. Pharmaceutical availablity generally is restricted to urban areas, but production capabilities are limited. Lower-income economies; significant support provided by outside assistance. Health care is a low national priority. Countries with least developed health-care infrastructure. Medical care generally is unavailable or much of the population is poorly served. Primary, secondary, and tertiary health care availabliity depends on humanitarian organizations. Pharmaceutical availability depends on humanitarian organizations. Health expenditures depend on outside assistance; lowest income economies. Health care is not a national priority. Excellent Good Fair Poor Unsuitable United Kingdom United Kingdom United Kingdom France France France Germany Germany Germany Austria Austria Austria Belgium Belgium Belgium Estonia Estonia Hungary Ireland Ireland Ireland Italy Italy Italy Lithuania Switz. Switz. Switz. Albania Albania Mace. Mace. Kos. Kos. Netherlands Netherlands Norway Norway Norway Czech Republic Serbia Slovenia Slovenia Bos. & Her. Slovakia Slovakia Spain Spain Spain Sweden Sweden Sweden Croatia Croatia Denmark Denmark Denmark Lux. Lux. Lux. Mont. Mont. Malta Poland Rus. Latvia Andorra Andorra Andorra Monaco Monaco Monaco San Marino San Marino San Marino Guyana Trinidad and Tobago Grenada Barbados St. Lucia St. Vincent and the Grenadines St. Kitts and Nevis Jamaica Colombia Venezuela Cuba Panama Haiti Dominican Republic Dominica Antigua and Barbuda Brazil Netherlands Antilles (Neth.) Netherlands Antilles (Neth.) Guadeloupe (France) Martinique (France) Suriname The Bahamas French Guiana (France) Afg. Djibouti Egypt Sudan Ethiopia Eritrea Yemen Oman U.A.E. Iraq Jordan Saudi Arabia Qatar Bahrain Kuwait Syria Lebanon Israel Cyprus Iran Turkmenistan Azerbaijan Armenia Turkey Pal. Auth. Uganda Rwanda Sudan Malaysia Singapore Timor-Leste Maldives Laos Thailand Burma Tanzania Kenya Costa Rica Guatemala Nicaragua Indonesia Zambia Cote d’Ivoire Senegal The Gambia Gabon Guinea Sierra Leone Angola Niger Nigeria Liberia Papua New Guinea Japan Peru Paraguay Argentina Chile Chile Mexico Algeria Tunisia Malawi Mozambique Zimbabwe Lesotho Swaziland Dem. Rep. of the Congo Greece Greece Greece Ghana Chad Benin Togo Sao Tome & Prin. Burkina Faso Burundi Canada Canada Canada United States Belize Philippines Australia Australia Australia New Zealand Madagascar South Africa Botswana Cameroon Equa. Gui. Ethiopia Somalia Cen. Afr. Rep. Pakistan Bangladesh Sri Lanka Brunei Cambodia Vietnam Bhutan Nepal North Korea South Korea Bulgaria Ukraine Uzbekistan Georgia Comoros Seychelles Mauritius Rep. of the Congo The Bahamas Solomon Islands Kiribati Tuvalu Nauru Fiji Tonga Vanuatu Palau Samoa Ecuador Iceland Kyrgyzstan Tajikistan Afghanistan Afghanistan Afghanistan Mali Marshall Islands Federated States of Micronesia Moldova Romania Belarus Finland Morocco Portugal Portugal Uruguay Mauritania Guinea-Bissau Brazil Bolivia El Salvador Honduras Suriname Russia China Mongolia India Libya Kazakhstan Namibia DI Cartography Center/MPG 784436AI (G00909) 11-08 Western Sahara French Polynesia (France) Taiwan New Caledonia (France)
Transcript of Europe inset Middle East inset Health-Care Capabilities ... Report_ICA Global Health 2008...
Area ofEuropeinset
Area ofMiddle East
inset
Area ofCaribbean
inset
Caribbean inset
Europe inset Middle East inset
Caribbean inset
Health-Care Capabilities
Boundary representation isnot necessarily authoritative.
Source: National Center for Medical Intelligence.
Countries with modern health-care infrastructure,providing high-quality care to most of the population.
Pharmaceutical availability and production capability are excellent.
These high-income economies have more thansufficient budgetary resources.
Health care and public health education are a high national priority.
Countries with developed health--care infrastructure,with quality care available to a large percentage ofthe population.
Pharmaceuticals usually are available; productioncapability is adequate.
Upper-middle-income economies, with sufficient budgetary resources to meet the needs of the population.
Health care is a high national priority.
Countries with developed health-care infrastructure.Medical care generally is available, but relatively large sectors of the population lack adequate care. Tertiarycare generally is available, at least in major urban areas; primary health care exists but is underdeveloped.
Pharmaceutical availability is good in urban areas; minimally available in rural areas. Production capabilitiesare generally limited but may be under rapid development.
Lower-middle-income economies; budgetary resources generally are available but often are not efficiently used.
Health care is of national importance but may be overshadowed by other pressing demands (i.e., political instability, conflict).
Countries with less developed health-care infrastructure.Medical care is unavailable to large sectors of the population. Tertiary care is minimally available; primary and secondary health care is rudimentary.
Pharmaceutical availablity generally is restricted to urban areas, but production capabilities are limited.
Lower-income economies; significant support provided by outside assistance.
Health care is a low national priority.
Countries with least developed health-care infrastructure.Medical care generally is unavailable or much of thepopulation is poorly served. Primary, secondary, and tertiary health care availabliity depends on humanitarian organizations.
Pharmaceutical availability depends on humanitarianorganizations.
Health expenditures depend on outside assistance; lowest income economies.
Health care is not a national priority.
Excellent Good Fair Poor Unsuitable
UnitedKingdomUnited
KingdomUnited
Kingdom
FranceFranceFrance
GermanyGermanyGermany
AustriaAustriaAustria
BelgiumBelgiumBelgium
EstoniaEstonia
Hungary
IrelandIrelandIreland
ItalyItalyItaly
Lithuania
Switz.Switz.Switz.
AlbaniaAlbania
Mace.Mace.Kos.Kos.
NetherlandsNetherlands
NorwayNorwayNorway
CzechRepublic
SerbiaSloveniaSlovenia
Bos. &Her.
SlovakiaSlovakia
SpainSpainSpain
SwedenSwedenSweden
CroatiaCroatia
DenmarkDenmarkDenmark
Lux.Lux.Lux.
Mont.Mont.
Malta
Poland
Rus.
Latvia
AndorraAndorraAndorra MonacoMonacoMonaco
San Marino
San Marino
San Marino
Guyana
Trinidadand
Tobago
GrenadaBarbados
St. LuciaSt. Vincent and the Grenadines
St. Kitts and Nevis
Jamaica
Colombia
Venezuela
Cuba
Panama
Haiti
Dominican Republic
Dominica
Antigua andBarbuda
Brazil
Netherlands Antilles (Neth.)Netherlands
Antilles (Neth.)
Guadeloupe (France)
Martinique (France)
Suriname
The Bahamas
French Guiana(France)
Afg.
Djibouti
Egypt
Sudan
Ethiopia
Eritrea Yemen
Oman
U.A.E.
Iraq
Jordan
SaudiArabia
Qatar
Bahrain
Kuwait
SyriaLebanon
Israel
Cyprus
Iran
TurkmenistanAzerbaijanArmenia
Turkey
Pal. Auth.
Uganda
Rwanda
Sudan
Malaysia Singapore
Timor-Leste
Maldives
Laos
Thailand
Burma
Tanzania
KenyaCosta Rica
Guatemala
Nicaragua
I n d o n e s i a
Zambia
Coted’Ivoire
Senegal The Gambia
Gabon
Guinea Sierra Leone
Angola
Niger
Nigeria
Liberia
Papua NewGuinea
Japan
Peru
Paraguay
ArgentinaChileChile
Mexico
Algeria
Tunisia
Malawi
Mozambique
Zimbabwe
Lesotho
Swaziland
Dem.Rep.
of theCongo
GreeceGreeceGreece
Ghana
Chad
Benin
Togo
Sao Tome& Prin.
BurkinaFaso
Burundi
CanadaCanadaCanada
United States
Belize
Philippines
A u s t r a l i aA u s t r a l i aA u s t r a l i a
NewZealand
Madagascar
SouthAfrica
Botswana
CameroonEqua.Gui.
Ethiopia
Somalia
Cen. Afr.Rep.
Pakistan
Bangladesh
Sri Lanka Brunei
Cambodia
Vietnam
BhutanNepal
North Korea
South Korea
Bulgaria
Ukraine
UzbekistanGeorgia
Comoros
Seychelles
Mauritius
Rep. ofthe Congo
The Bahamas
SolomonIslands
Kiribati
Tuvalu
Nauru
Fiji TongaVanuatu
Palau
Samoa
Ecuador
Iceland
Kyrgyzstan
Tajikistan
AfghanistanAfghanistanAfghanistan
Mali
MarshallIslands
Federated Statesof Micronesia
Moldova
Romania
Belarus
Finland
Morocco
PortugalPortugal
Uruguay
Mauritania
Guinea-Bissau
Brazil
Bolivia
El Salvador Honduras Suriname
Russia
China
Mongolia
India
Libya
Kazakhstan
Namibia
DI Cartography Center/MPG 784436AI (G00909) 11-08
Western Sahara
French Polynesia (France)
Taiwan
New Caledonia (France)
